Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

60 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Log reduction of leukemic cells and minimal residual disease by flow cytometry represent effective predictors of clinical outcome in elderly patients with acute myeloid leukemia.
Rossi G, Giambra V, de Waure C, Giacchetta I, Minervini MM, Abbenante MC, Spadano R, La Torre A, Scalzulli PR, Cascavilla N. Rossi G, et al. Among authors: giambra v. Cytometry B Clin Cytom. 2022 Jan;102(1):26-33. doi: 10.1002/cyto.b.22010. Epub 2021 May 13. Cytometry B Clin Cytom. 2022. PMID: 33983682 Free article.
Minimal residual disease and log-reduction of plasma cells are associated with superior response after double autologous stem cell transplant in younger patients with multiple myeloma.
Rossi G, Falcone AP, Minervini MM, De Cillis GP, De Waure C, Sisti LG, Giambra V, Valente D, Chiello V, Scalzulli PR, Carella AM, Cascavilla N. Rossi G, et al. Among authors: giambra v. Cytometry B Clin Cytom. 2019 May;96(3):195-200. doi: 10.1002/cyto.b.21755. Epub 2018 Dec 13. Cytometry B Clin Cytom. 2019. PMID: 30549231 Free article.
Leukemia-associated immunophenotypes subdivided in "categories of specificity" improve the sensitivity of minimal residual disease in predicting relapse in acute myeloid leukemia.
Rossi G, Giambra V, Minervini MM, De Waure C, Mancinelli S, Ciavarella M, Sinisi NP, Scalzulli PR, Carella AM, Cascavilla N. Rossi G, et al. Among authors: giambra v. Cytometry B Clin Cytom. 2020 May;98(3):216-225. doi: 10.1002/cyto.b.21855. Epub 2019 Nov 7. Cytometry B Clin Cytom. 2020. PMID: 31697027 Free article.
COVID-19 Specific Immune Markers Revealed by Single Cell Phenotypic Profiling.
Sansico F, Miroballo M, Bianco DS, Tamiro F, Colucci M, Santis E, Rossi G, Rosati J, Di Mauro L, Miscio G, Mazza T, Vescovi AL, Mazzoccoli G, Giambra V, On Behalf Of Css-Covid Group. Sansico F, et al. Among authors: giambra v. Biomedicines. 2021 Nov 29;9(12):1794. doi: 10.3390/biomedicines9121794. Biomedicines. 2021. PMID: 34944610 Free PMC article.
Noncanonical β-catenin interactions promote leukemia-initiating activity in early T-cell acute lymphoblastic leukemia.
Panelli P, De Santis E, Colucci M, Tamiro F, Sansico F, Miroballo M, Murgo E, Padovano C, Gusscott S, Ciavarella M, Chavez EA, Bianchi F, Rossi G, Carella AM, Steidl C, Weng AP, Giambra V. Panelli P, et al. Among authors: giambra v. Blood. 2023 Mar 30;141(13):1597-1609. doi: 10.1182/blood.2022017079. Blood. 2023. PMID: 36315912 Free PMC article.
The circadian clock circuitry modulates leukemia initiating cell activity in T-cell acute lymphoblastic leukemia.
Murgo E, De Santis E, Sansico F, Melocchi V, Colangelo T, Padovano C, Colucci M, Carbone A, Totti B, Basti A, Gottschlich L, Relogio A, Capitanio N, Bianchi F, Mazzoccoli G, Giambra V. Murgo E, et al. Among authors: giambra v. J Exp Clin Cancer Res. 2023 Aug 24;42(1):218. doi: 10.1186/s13046-023-02799-7. J Exp Clin Cancer Res. 2023. PMID: 37620852 Free PMC article.
60 results